関連する実験動画
Updated: Feb 16, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.5K
抗真菌薬の組織製薬:レビュー
Felix Bergmann1, Marlene Prager1, Lena Pracher1
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
International journal of antimicrobial agents
|February 14, 2026
まとめ
プラズマの薬剤濃度は,侵入性真菌感染症の組織における抗真菌薬の暴露を予測しない可能性があります. 組織薬動力学 (PK) は,重症患者の抗真菌投与と治療成功の最適化に不可欠です.
科学分野:
- 薬理学 薬理学とは
- 感染症 感染症は感染症です.
- 臨床薬局 臨床薬局について
背景:
- 侵襲性真菌感染症は,特に免疫力が低下した個人に重大なリスクをもたらします.
- 現在の抗真菌薬の投与量は,プラズマの薬動力学 (PK) に大きく依存しています.
- プラズマPKは,感染部位における薬剤濃度を正確に反映しない可能性があり,治療の有効性に影響を及ぼします.
研究 の 目的:
- 承認された抗真菌剤の組織薬動力学 (PK) に関する臨床データをレビューする.
- 様々な抗真菌薬のクラスによる組織浸透を比較する.
- 抗真菌治療の指針として,組織薬物曝露の重要性を強調する.
主な方法:
- 2025年7月までの将来的なヒト試験のためのPubMedの体系的な文献検索.
- 血と組織における薬物濃度の両方を報告した研究が含まれています.
- 承認された抗真菌剤に焦点を当てたもの:トリアゾール,エキノカンジン,アンフォテリシンB,フルスチトシン.
主要な成果:
- 異なる組織やコンパートメントにわたる抗真菌薬の浸透度において顕著な変動が観察されました.
- 組織の薬物濃度が常にプラズマPKプロファイルと相関するとは限らない.
- 薬剤の浸透率は,トリアゾール,エキノカンジン,アンフォテリシンB,フルシトシンの間で顕著に変化した.
結論:
- 抗真菌剤の用量については,血濃度のみに頼るだけでは不十分です.
- 組織への浸透は,治療の成功を達成する上で重要な要因です.
- 抗真菌剤の選択と投与は,患者のアウトカムを改善するために,組織PKデータを組み込む必要があります.
関連する概念動画
Pharmacokinetics: Drug–Drug Interactions
477
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
477
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
272
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
272
Pharmacokinetics in Pediatric Patients: Drug Excretion
281
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
256
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717

